Literature DB >> 17067664

Acute treatment with 5-HT3 receptor antagonist, tropisetron, reduces immobility in intact female rats exposed to the forced swim test.

Gabriela Bravo1, Sharmin Maswood.   

Abstract

The effects of tropisetron, a 5-HT3 receptor antagonist, were evaluated in adult Fischer female rats exposed to the Forced Swim Test (FST). Rats selected on the days of proestrus or estrus was immersed in a cylinder of water for 2 consecutive days. Rats were exposed to the FST for 15 min on day 1 (pretest), followed by a 5-min session (test), 24 h later. The proestrous-estrous group consisted of rats that were exposed to the FST on their proestrous stage (pretest); then 24 h later the same rats were exposed to the FST on their estrous stage (test). Rats in the estrous-diestrous group were exposed to the FST on their estrous stage (pretest) and 24 h later on their diestrous stage (test). Rats were injected intraperitoneally with saline or 1.0 or 2.0 mg/kg tropisetron 30 min prior to exposure to the cylinder on the test day. Immobility, swimming, and struggling behaviors were scored for 5 min. There was a significant decline in immobility after treatment with 2.0 mg/kg tropisetron in both groups. In addition, a significant decline in swimming was observed in the estrous rats (proestrous-estrous group) after treatment with 2.0 mg/kg tropisetron. There were no significant effects of tropisetron on struggling in any groups examined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17067664     DOI: 10.1016/j.pbb.2006.09.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

Review 1.  The role of serotonin receptor subtypes in treating depression: a review of animal studies.

Authors:  Gregory V Carr; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-11-24       Impact factor: 4.530

2.  Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.

Authors:  Deepali Gupta; Mahesh Radhakrishnan; Yeshwant Kurhe; Devadoss Thangaraj; Visakh Prabhakar; Prateek Kanade
Journal:  Acta Pharmacol Sin       Date:  2014-11-24       Impact factor: 6.150

Review 3.  Sex differences in animal models of psychiatric disorders.

Authors:  N Kokras; C Dalla
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

4.  Pharmacological evaluation of novel 5-HT3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery.

Authors:  Deepali Gupta; Mahesh Radhakrishnan; Devadoss Thangaraj; Yeshwant Kurhe
Journal:  J Pharm Bioallied Sci       Date:  2015 Apr-Jun

5.  Adenylyl Cyclase (AC) Mediates the Antidepressant-Like Effects of Tropisetron on a Mouse Model of Maternal Separation Stress.

Authors:  Ali Hosseinzadeh; Shakiba Nasiri Boroujeni; Elham Saghaei; Zahra Loriooini; Saeid Habibian Dehkordi; Shima Balali-Dehkordi; Mohammad Rahimi-Madiseh; Hossein Amini-Khoei
Journal:  Depress Res Treat       Date:  2021-04-22

Review 6.  The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference.

Authors:  Nina K Popova; Anton S Tsybko; Vladimir S Naumenko
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

7.  Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT(3) receptor antagonist: an investigation in behaviour-based rodent models of depression.

Authors:  Radhakrishnan Mahesh; Baldev Kumar; Ankur Jindal; Shvetank Bhatt; Thangaraj Devadoss; Dilip Kumar Pandey
Journal:  Indian J Pharmacol       Date:  2012 Sep-Oct       Impact factor: 1.200

8.  Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models.

Authors:  R Rajkumar; R Mahesh
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

9.  Antidepressant-like effect of a novel 5-HT3 receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests.

Authors:  Yeshwant Kurhe; Radhakrishnan Mahesh; Thangaraj Devadoss; Deepali Gupta
Journal:  J Pharmacol Pharmacother       Date:  2014-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.